In particular, the mechanism of action of IL-18 in cancer progression involves hypoxia, which induces the transcription and secretion of IL-18, followed by the expression of hypoxia-inducible factor-1α (HIF-1α) [33]. This evidence concerns the gene IL18 and cancer.